Increased antitumor capability of fiber-modified adenoviral vector armed with TRAIL against bladder cancers

Bladder Cancer in 2010: How Far have We Come?

(2010) B. L. Jacobs et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Expression of miR-122 mediated by adenoviral vector induces apoptosis and cell cycle arrest of cancer cells.

(2010) Leina Ma et al.   CANCER BIOLOGY & THERAPY

AdCD40L Immunogene Therapy for Bladder Carcinoma--The First Phase I/IIa Trial

(2010) P.-U. Malmstrom et al.   CLINICAL CANCER RESEARCH

5/35 Fiber-Modified Conditionally Replicative Adenovirus Armed with p53 Shows Increased Tumor-Suppressing Capacity to Breast Cancer Cells

(2010) Xiaoping He et al.   HUMAN GENE THERAPY

Bladder Cancer: Can We Move Beyond Chemotherapy?

(2010) Arlene Siefker-Radtke   Current Oncology Reports

Adenovirus delivery of human CD40 ligand gene confers direct therapeutic effects on carcinomas

(2009) L Vardouli et al.   CANCER GENE THERAPY

Clinical Adenoviral Gene Therapy for Prostate Cancer

(2009) Ellen Schenk et al.   HUMAN GENE THERAPY

Local AdCD40L Gene Therapy is Effective for Disseminated Murine Experimental Cancer by Breaking T-cell Tolerance and Inducing Tumor Cell Growth Inhibition

(2009) Camilla Lindqvist et al.   JOURNAL OF IMMUNOTHERAPY

Construction of Urothelium-Specific Recombinant Adenovirus and Its Inhibition in Bladder Cancer Cell

(2009) Xiang-Dong He et al.   UROLOGIA INTERNATIONALIS

Tumor-Selective Replication of an Oncolytic Adenovirus Carrying Oct-3/4 Response Elements in Murine Metastatic Bladder Cancer Models

(2008) C.-L. Wu et al.   CLINICAL CANCER RESEARCH